• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB1300125 重组人胰岛素注射液 human insulin Injection Biological Products Supplementary Application 2013-06-03 Lilly France Lilly France Certificate Issued 2015-01-26 view
JYSB1000071 精蛋白锌重组人胰岛素注射液 Protamine Zinc Recombinant Human Insulin Injection Biological Products Supplementary Application 2010-04-15 Lilly France Lilly France Certificate Issued 2010-09-09 view
JYSB2000528 精蛋白锌重组人胰岛素注射液 Protamine Zinc Recombinant Human Insulin Injection Biological Products Supplementary Application 2020-10-22 Lilly France Lilly France In Review 2020-10-21 view
JYSB2000076 精蛋白锌重组人胰岛素混合注射液 Injection Biological Products Supplementary Application 2020-03-18 Lilly France Lilly France Certificate Issued 2021-02-26 view
JYSB2000267 精蛋白锌重组人胰岛素混合注射液 Injection Biological Products Supplementary Application 2020-06-18 Lilly France Lilly France Filed 2020-06-23 view
JYSB1700088 精蛋白锌重组人胰岛素注射液 Protamine Zinc Recombinant Human Insulin Injection Biological Products Supplementary Application 2017-05-03 Lilly France Lilly France In Review 2017-04-29 view
JYSB1100256 精蛋白锌重组人胰岛素混合注射液 Injection Biological Products Supplementary Application 2012-02-15 Lilly France Lilly France Certificate Issued 2012-11-08 view
JYSB1200148 精蛋白锌重组人胰岛素混合注射液 Injection Biological Products Supplementary Application 2012-06-12 Lilly France Lilly France Certificate Issued 2013-11-21 view
JYSB2000255 重组人胰岛素注射液 human insulin Injection Biological Products Supplementary Application 2020-06-18 Lilly France Lilly France Filed 2020-06-19 view
JYSB2000442 精蛋白锌重组人胰岛素混合注射液 Injection Biological Products Supplementary Application 2020-09-08 Lilly France Lilly France Filed 2020-09-18 view
JYSB1900182 精蛋白锌重组人胰岛素注射液 Protamine Zinc Recombinant Human Insulin Injection Biological Products Supplementary Application 2019-07-22 Lilly France Lilly France Certificate Issued 2019-11-01 view
JYHB1700478 注射用盐酸吉西他滨 Gemcitabine hydrochloride Lyophilized Chemical Drugs Supplementary Application 2017-04-14 LILLY FRANCE Lilly France Certificate Issued 2018-07-25 view
JYSZ1200092 重组人胰岛素注射液 human insulin Injection Biological Products License Renew 2012-12-22 Lilly France Lilly France Certificate Issued 2013-12-17 view
JYHB0900435 注射用盐酸吉西他滨 Gemcitabine hydrochloride Lyophilized Chemical Drugs Supplementary Application 2009-06-12 LILLY FRANCE Lilly France Certificate Issued 2010-06-10 view
JYSB2000507 精蛋白锌重组人胰岛素混合注射液 Injection Biological Products Supplementary Application 2020-10-13 Lilly France Lilly France Certificate Issued 2020-11-26 view
JXHL2000031 注射用盐酸吉西他滨 Gemcitabine hydrochloride Lyophilized Chemical Drugs(2.4) Import Drug Application 2020-02-22 LILLY FRANCE Lilly France In Review 2020-02-21 view
JYSB2000262 精蛋白锌重组人胰岛素注射液 Protamine Zinc Recombinant Human Insulin Injection Biological Products Supplementary Application 2020-06-18 Lilly France Lilly France Filed 2020-06-22 view
JYSB1700080 精蛋白锌重组人胰岛素混合注射液 Injection Biological Products Supplementary Application 2017-05-03 Lilly France Lilly France In Review 2017-04-29 view
JYSB1300127 精蛋白锌重组人胰岛素混合注射液 Injection Biological Products Supplementary Application 2013-06-03 Lilly France Lilly France Certificate Issued 2015-01-08 view
JYSB1000075 精蛋白锌重组人胰岛素混合注射液 Injection Biological Products Supplementary Application 2010-04-15 Lilly France Lilly France Certificate Issued 2010-09-09 view